Corcept Therapeutics
CORT
#2115
Rank
ยฃ7.10 B
Marketcap
ยฃ66.16
Share price
3.03%
Change (1 day)
23.66%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of March 2026 : ยฃ0.25 Billion

According to Corcept Therapeutics 's latest financial reports the company has ยฃ0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ0.27 B-9.54%
2024-12-31ยฃ0.30 B5.69%
2023-12-31ยฃ0.28 B-19%
2022-12-31ยฃ0.35 B115.46%
2021-12-31ยฃ0.16 B-48.78%
2020-12-31ยฃ0.32 B53.63%
2019-12-31ยฃ0.21 B29.2%
2018-12-31ยฃ0.16 B148.06%
2017-12-31ยฃ65.66 M57.21%
2016-12-31ยฃ41.76 M53.07%
2015-12-31ยฃ27.28 M75.19%
2014-12-31ยฃ15.57 M-53.19%
2013-12-31ยฃ33.26 M-42.2%
2012-12-31ยฃ57.55 M125.72%
2011-12-31ยฃ25.5 M60.16%
2010-12-31ยฃ15.92 M7.95%
2009-12-31ยฃ14.74 M18.06%
2008-12-31ยฃ12.49 M42.91%
2007-12-31ยฃ8.74 M81.07%
2006-12-31ยฃ4.82 M-71.37%
2005-12-31ยฃ16.86 M-13.44%
2004-12-31ยฃ19.48 M201.01%
2003-12-31ยฃ6.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ16.70 B 6,420.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.28 B 1,963.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ9.90 B 3,766.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ4.00 B 1,461.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ4.32 B 1,586.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.94 B 3,000.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ0.10 B-60.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ70.04 M-72.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.68 B 557.17%๐Ÿ‡บ๐Ÿ‡ธ USA